BIO-TECHNE Corp Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
BIO-TECHNE Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • BIO-TECHNE Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $6.57M.
  • BIO-TECHNE Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $25.6M, a 32.3% decline year-over-year.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2024 was $17.6M, a 67% decline from 2023.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2023 was $53.2M, a 39% increase from 2022.
  • BIO-TECHNE Corp annual Income Tax Expense (Benefit) for 2022 was $38.3M, a 346% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $25.6M $6.57M +$8.01M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $17.6M $1.07M -$11.8M -91.6% Apr 1, 2024 Jun 30, 2024 10-K 2024-08-22
Q1 2024 $29.3M $12M +$2.05M +20.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $27.3M $5.92M -$10.5M -63.9% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $37.8M -$1.44M -$15.4M -110% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $53.2M $12.8M -$4.3M -25.1% Apr 1, 2023 Jun 30, 2023 10-K 2024-08-22
Q1 2023 $57.5M $9.98M +$1.35M +15.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $56.2M $16.4M +$2.3M +16.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $53.9M $14M +$15.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $38.3M $17.1M +$24.7M Apr 1, 2022 Jun 30, 2022 10-K 2024-08-22
Q1 2022 $13.6M $8.63M +$8.68M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $4.94M $14.1M +$3.9M +38.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $1.05M -$1.6M -$7.54M -127% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $8.59M -$7.53M -$10.2M -381% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-23
Q1 2021 $18.8M -$48K -$10.4M -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $29.2M $10.2M -$20.5M -66.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-07
Q3 2020 $49.7M $5.94M +$2.54M +74.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $47.2M $2.68M -$3.65M -57.6% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-24
Q1 2020 $50.8M $10.4M +$5.17M +98.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $45.7M $30.7M +$26.5M +629% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-08
Q3 2019 $19.2M $3.41M +$3.23M +1762% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $15.9M $6.33M -$8.24M -56.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-25
Q1 2019 $24.2M $5.22M -$21K -0.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $24.2M $4.21M +$31.3M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 -$7.12M $183K -$6.92M -97.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$198K $14.6M +$4.33M +42.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-26
Q1 2018 -$4.53M $5.24M -$3.73M -41.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$800K -$27.1M -$34.8M -451% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $34M $7.1M -$1.84M -20.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $35.9M $10.2M -$1.91M -15.7% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-11-06
Q1 2017 $37.8M $8.97M -$3.23M -26.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $41M $7.72M -$1.8M -18.9% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $42.8M $8.94M -$197K -2.16% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $43M $12.1M +$231K +1.94% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-27
Q1 2016 $42.8M $12.2M -$2.27M -15.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $45M $9.52M +$169K +1.81% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $44.9M $9.14M -$1.55M -14.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $46.4M $11.9M -$714K -5.66% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-07
Q1 2015 $47.1M $14.5M +$41K +0.28% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $47.1M $9.35M -$1.81M -16.2% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $48.9M $10.7M -$1.54M -12.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $50.4M $12.6M +$274K +2.22% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-29
Q1 2014 $50.2M $14.4M +$3.08M +27.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $47.1M $11.2M -$919K -7.61% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $48M $12.2M -$92K -0.75% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $48.1M $12.4M -$1.02M -7.65% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-31
Q1 2013 $49.1M $11.3M -$101K -0.88% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $49.2M $12.1M +$22K +0.18% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-04
Q3 2012 $49.2M $12.3M -$661K -5.09% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $49.9M $13.4M -$1.26M -8.63% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-29
Q1 2012 $51.1M $11.4M -$2.87M -20% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $54M $12.1M +$921K +8.27% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 $53.1M $13M +$399K +3.17% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $52.7M $14.6M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-29
Q1 2011 $14.3M +$5.27M +58.2% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $11.1M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-07
Q3 2010 $12.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q1 2010 $9.05M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.